January 2002
·
3 Reads
·
4 Citations
The BMJ
What is this page?
This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.
Publications (1)
Citations (1)
... According to Julia Greenstein, CEO, Immerge Biotherapeutics, Inc., whose company claimed to have knocked out the GATA1 gene, " Another advantage is that preliminary research shows that cells from this line of pigs, in contrast to most other cells tested don't have the capacity to spread porcine endogenous retrovirus to human cells in culture." [ 12 ] The potential market for pig organs is huge. PPL Therapeutics (Edinburgh) says that analysts put the value of the market for solid organs at $5bn (£3.6bn; €5.7bn), and cellular therapies for diabetes, Parkinson's disease, and Alzheimer's disease could be worth another $6bn [ 12 ] . ...
- Citing Article
January 2002
The BMJ